Tammy F. Chu
-
- Chemotherapy-induced cardiotoxicity and mitigation 4
- Oncology top 5%
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 3
-
- Sarcoma Diagnosis and Treatment 1
- Renal cell carcinoma treatment 1
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment 1
-
- PI3K/AKT/mTOR signaling in cancer 2
-
- Inflammatory mediators and NSAID effects 1
-
- Cardiac Imaging and Diagnostics 1
- Co-authors
- Ming Hui ChenRisto KerkeläKathleen C. WoulfeThomas ForceGeorge D. DemetriDavid M. HarrisFrederick J. SchöenAnnick D. Van den Abbeele
- Partner nations
- United StatesNetherlandsChina
In The Last Decade
Tammy F. Chu
6 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Cardiology and Cardiovascular Medicine 635
- Oncology 461
- Hematology 133
- Pulmonary and Respiratory Medicine 280
- Gastroenterology 41
Countries citing papers authored by Tammy F. Chu
This map shows the geographic impact of Tammy F. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tammy F. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tammy F. Chu more than expected).
Fields of papers citing papers by Tammy F. Chu
This network shows the impact of papers produced by Tammy F. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tammy F. Chu. The network helps show where Tammy F. Chu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tammy F. Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2014 | 7 | |
| 3 | 2009 | 187 | |
| 4 | 2009 | 4 | |
| 5 | 2008 | 2 | |
| 6 | Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibbreakdown → | 2007 | 814 |
About Tammy F. Chu
Tammy F. Chu is a scholar working on Hematology, Gastroenterology and Cardiology and Cardiovascular Medicine, having authored 6 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Inflammatory mediators and NSAID effects (1 paper), Gastrointestinal Tumor Research and Treatment (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Cardiac Imaging and Diagnostics (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (635 citations), Oncology (461 citations) and Hematology (133 citations). Tammy F. Chu has collaborated with scholars based in United States, Netherlands and China. Frequent co-authors include Ming Hui Chen, Risto Kerkelä, Kathleen C. Woulfe, Thomas Force, George D. Demetri, David M. Harris, Frederick J. Schöen, Annick D. Van den Abbeele, Jey-Hsin Chen and Jayesh Desai.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.